Supply report · August 2026 register copy
Diabetes in Nigeria: the registration data
Across the 10 diabetes molecules Ogbogwu tracks, our August 2026 copy of the NAFDAC Greenbook lists 150 active registrations held by 54 companies — plus 116 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 150
- Companies
- 54
- New in the last 12 months
- 11
- Renewals due within a year
- 26
Who holds the registrations
The ten companies with the most active diabetes registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Getz Pharma Nigeria— 14 active
- 2.Novo Nordisk Pharma— 10 active
- 3.Merck Pharmaceutical and Life Sciences— 8 active
- 4.Micro Nova Pharmaceuticals Ind— 8 active
- 5.May & Baker— 7 active
- 6.Mega Lifesciences Nigeria— 6 active
- 7.Novartis Nigeria— 6 active
- 8.Phillips Pharmaceuticals (Nigeria)— 6 active
- 9.CHI Pharmaceutical— 5 active
- 10.Geneith Pharmaceuticals— 5 active
Where the products are made
Maker country as the register records it, across the 150 active registrations (15 rows carry no country in our copy).
- India— 57 (38%)
- Nigeria— 22 (15%)
- Pakistan— 18 (12%)
- Bangladesh— 8 (5%)
- Germany— 6 (4%)
- France— 5 (3%)
- Spain— 4 (3%)
- Egypt— 3 (2%)
Dosage forms
- Tablet— 112 active
- Suspension for injection— 15 active
- Solution for injection— 14 active
- Caplet— 6 active
- Capsule— 1 active
- Injection— 1 active
- Prolonged-release tablet— 1 active
Newest registrations
The latest diabetes approvals in our copy — 11 products were registered in the twelve months to August 2026.
26 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Metformin — 35 active registrations
- Insulin — 21 active registrations
- Glimepiride — 17 active registrations
- Vildagliptin — 6 active registrations
- Empagliflozin — 5 active registrations
- Dapagliflozin — 4 active registrations
- Glibenclamide — 4 active registrations
- Liraglutide — 0 active registrations
- Semaglutide — 0 active registrations
- Tirzepatide — 0 active registrations
“Diabetes” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Metformin 500 mg tablet — 21 companies
- Glimepiride 2 mg tablet — 10 companies
- Metformin 1000 mg tablet — 6 companies
- Vildagliptin 50 mg tablet — 5 companies
- Glimepiride 4 mg tablet — 4 companies
- Insulin 300 units/3 mL solution for injection — 4 companies
Manufacturing or exporting diabetes medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.